These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 37496754)

  • 1. The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer.
    Sharon S; Daher-Ghanem N; Zaid D; Gough MJ; Kravchenko-Balasha N
    Front Oral Health; 2023; 4():1180869. PubMed ID: 37496754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Checkpoint Inhibitors, Small-Molecule Immunotherapies and the Emerging Role of Neutrophil Extracellular Traps in Therapeutic Strategies for Head and Neck Cancer.
    O'Meara CH; Jafri Z; Khachigian LM
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Status of Cervical Lymph Nodes in Head and Neck Cancer-A Surgical Oncology Perspective.
    Nakamura H; Ogawa T; Yamanaka S; Inukai D; Maruo T; Takahara T; Satou A; Tsuzuki T; Suzuki S; Ueda R; Fujimoto Y
    J Pers Med; 2023 Jul; 13(7):. PubMed ID: 37511787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck.
    Johnson JM; Vathiotis IA; Harshyne LA; Ali A; Bar Ad V; Axelrod R; Lorber E; Curry J; Cognetti DM; Luginbuhl AJ; Tuluc M; Keith S; Mahoney MG; Argiris A
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37536941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized Drug Delivery Systems: An Update on Treatment Options for Head and Neck Squamous Cell Carcinomas.
    Hariharan A; Tran SD
    Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous immune-related adverse events to immune checkpoint inhibitors: from underlying immunological mechanisms to multi-omics prediction.
    Cao T; Zhou X; Wu X; Zou Y
    Front Immunol; 2023; 14():1207544. PubMed ID: 37497220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell RNA sequencing reveals tumor immune microenvironment in human hypopharygeal squamous cell carcinoma and lymphatic metastasis.
    Li C; Guan R; Li W; Wei D; Cao S; Xu C; Chang F; Wang P; Chen L; Lei D
    Front Immunol; 2023; 14():1168191. PubMed ID: 37503341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Immunotherapy and Radiation Therapy in Gastrointestinal Cancers: An Appraisal of the Current Literature and Ongoing Research.
    Kumar R; Kim J; Deek MP; Eskander MF; Gulhati P; In H; Kennedy T; Shah MM; Grandhi MS; Berim L; Spencer KR; Langan RC; Hochster HS; Boland PM; Jabbour SK
    Curr Oncol; 2023 Jul; 30(7):6432-6446. PubMed ID: 37504333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer.
    Ye W; Li M; Luo K
    Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37513975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.
    Zibelman M; MacFarlane AW; Costello K; McGowan T; O'Neill J; Kokate R; Borghaei H; Denlinger CS; Dotan E; Geynisman DM; Jain A; Martin L; Obeid E; Devarajan K; Ruth K; Alpaugh RK; Dulaimi EA; Cukierman E; Einarson M; Campbell KS; Plimack ER
    Nat Commun; 2023 Jul; 14(1):4513. PubMed ID: 37500647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Dose Non-Targeted Effects and Mitochondrial Control.
    Averbeck D
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Radiotherapy in Combination with Immunotherapy in Treatment of Advanced Recurrent Squamous Cell Carcinoma of the Larynx.
    Polanowski P; Nasiek A; Grządziel A; Pietruszka A; Składowski K; Polanowska K
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta.
    O'Connor RA; Martinez BR; Koppensteiner L; Mathieson L; Akram AR
    Front Immunol; 2023; 14():1221532. PubMed ID: 37520560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Clinical Trials to Advance the Study of Immune Checkpoint Inhibitor Toxicity.
    Cluxton C; Naidoo J
    Curr Oncol; 2023 Jul; 30(7):6862-6871. PubMed ID: 37504362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-Induced Oropharyngeal Squamous Cell Carcinoma: Case Report and Review of the Literature.
    Giannini L; Alliata A; Cristofaro V; Incandela F; Pompilio M; Ottini A; Cavalieri S; Nuzzolese I; Iacovelli NA; Franceschini M; Deganello A
    Curr Oncol; 2023 Jul; 30(7):6708-6719. PubMed ID: 37504352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer.
    Nadal E; Saleh M; Aix SP; Ochoa-de-Olza M; Patel SP; Antonia S; Zhao Y; Gueorguieva I; Man M; Estrem ST; Liu J; Avsar E; Lin WH; Benhadji KA; Gandhi L; Guba SC; Diaz IA
    BMC Cancer; 2023 Jul; 23(1):708. PubMed ID: 37507657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transposable elements potentiate radiotherapy-induced cellular immune reactions via RIG-I-mediated virus-sensing pathways.
    Du J; Kageyama SI; Yamashita R; Tanaka K; Okumura M; Motegi A; Hojo H; Nakamura M; Hirata H; Sunakawa H; Kotani D; Yano T; Kojima T; Hamaya Y; Kojima M; Nakamura Y; Suzuki A; Suzuki Y; Tsuchihara K; Akimoto T
    Commun Biol; 2023 Aug; 6(1):818. PubMed ID: 37543704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body bioluminescence imaging of T-cell response in PDAC models.
    McMorrow R; Zambito G; Nigg A; Lila K; van den Bosch TPP; Lowik CWGM; Mezzanotte L
    Front Immunol; 2023; 14():1207533. PubMed ID: 37497236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and senescence in the immune microenvironment of osteosarcoma: focus on new therapeutic strategies.
    Ying H; Li ZQ; Li MP; Liu WC
    Front Endocrinol (Lausanne); 2023; 14():1217669. PubMed ID: 37497349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prognostic nomogram for predicting recurrence-free survival of stage I-III colon cancer based on immune-infiltrating Treg-related genes.
    Xu L; Liu M; Lian J; Li E; Dongmin C; Li X; Wang W
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13523-13543. PubMed ID: 37498396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.